During the Health System Executive Summit, Candy Tsourounis, PharmD, and Elise Wozniak, PharmD got candid about the barriers and financial risk surrounding this innovative therapy.
News|Articles|March 2, 2012
Careers Page for Medical and Healthcare Executives
Visit our Careers page for Medical and Healthcare Executives, which is updated regularly, to search for postings by date, location, and company name. You may also research salaries by using the PayScale tool link on the site.
Advertisement
Advertisement
Related to this article
Foundational Pharmacy Strategies’ Christine Johnston on how rebate structures, pending legislation, and a stalled pipeline are reshaping — and threatening — the biosimilar market heading into 2027.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
More pluses for GLP-1s for obstructive sleep apnea | CHEST 2026
2
Long-acting lenacapavir plus cabotegravir kept all 46 patients with HIV virally suppressed in recent trial
3
Is there a dangerous 'weekend effect' to hospitals admissions? The verdict is split | CHEST 2026
4
Experts say cost barriers and stigma keep eligible adults from lung cancer screening
5